Research Article
Open Randomized Clinical Trial on JWSJZ Decoction for the Treatment of ALS Patients
Table 1
Baseline clinical characteristics of the two ALS groups.
| Subjects | JWSJZ group () | Control group () | value |
| Age (years) | 51.6 ± 7.2 | 50.1 ± 4.2 | 0.89 | Men/Women | 14/9 | 11/8 | — | Disease duration (months) | 25.9 ± 24.7 | 26.1 ± 24.9 | 0.37 | Mean time from diagnosis (months) | 18.35 ± 16.78 | 17.59 ± 13.51 | 0.29 | Area where ALS first developed—limbs/bulbar/both | 18/3/3 | 19/2/3 | — | ALSFRS | 37.1 ± 7.6 | 37.4 ± 9.2 | 0.65 |
|
|